Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs prophylactic platelet transfusion in ASCT
NCT04448184Phase 3Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Feb 2022
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in hemorrhage, sponsored by Ottawa Hospital Research Institute. Started Feb 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04448184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448184.